BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $442 | +81.9% | 11,714 | +120.0% | 0.04% | +184.6% |
| Q2 2023 | $243 | -46.7% | 5,325 | -40.5% | 0.01% | -35.0% |
| Q1 2023 | $456 | 0.0% | 8,944 | 0.0% | 0.02% | 0.0% |
| Q4 2022 | $456 | -99.9% | 8,944 | -15.3% | 0.02% | -23.1% |
| Q3 2022 | $569,000 | +12.0% | 10,559 | +33.6% | 0.03% | +36.8% |
| Q2 2022 | $508,000 | -27.1% | 7,903 | -2.7% | 0.02% | 0.0% |
| Q4 2021 | $697,000 | +119.9% | 8,122 | +106.2% | 0.02% | +90.0% |
| Q3 2021 | $317,000 | -50.7% | 3,939 | -48.3% | 0.01% | -58.3% |
| Q1 2021 | $643,000 | +103.5% | 7,624 | +93.8% | 0.02% | +84.6% |
| Q4 2020 | $316,000 | +26.9% | 3,933 | +27.0% | 0.01% | +8.3% |
| Q3 2020 | $249,000 | -14.7% | 3,096 | -13.8% | 0.01% | -36.8% |
| Q1 2020 | $292,000 | -35.0% | 3,592 | -33.1% | 0.02% | -24.0% |
| Q4 2019 | $449,000 | -44.1% | 5,372 | -41.5% | 0.02% | -55.4% |
| Q3 2019 | $803,000 | -0.9% | 9,179 | -7.2% | 0.06% | +75.0% |
| Q2 2019 | $810,000 | -17.8% | 9,893 | -18.3% | 0.03% | -20.0% |
| Q1 2019 | $985,000 | +176.7% | 12,110 | +124.0% | 0.04% | +37.9% |
| Q4 2018 | $356,000 | -47.7% | 5,406 | -38.8% | 0.03% | +16.0% |
| Q3 2018 | $681,000 | -51.5% | 8,834 | -53.6% | 0.02% | -51.0% |
| Q2 2018 | $1,405,000 | +134.9% | 19,028 | +107.1% | 0.05% | +183.3% |
| Q1 2018 | $598,000 | -76.7% | 9,188 | -76.8% | 0.02% | -74.3% |
| Q4 2017 | $2,562,000 | +16.7% | 39,633 | +13.2% | 0.07% | +16.7% |
| Q3 2017 | $2,196,000 | +1.0% | 34,997 | -2.6% | 0.06% | -6.2% |
| Q2 2017 | $2,175,000 | +35.7% | 35,929 | +16.3% | 0.06% | +30.6% |
| Q1 2017 | $1,603,000 | +159.4% | 30,906 | +121.6% | 0.05% | +172.2% |
| Q4 2016 | $618,000 | -64.1% | 13,947 | -61.4% | 0.02% | -75.0% |
| Q3 2016 | $1,722,000 | +0.5% | 36,167 | -4.6% | 0.07% | -6.5% |
| Q2 2016 | $1,714,000 | +0.5% | 37,897 | -8.7% | 0.08% | -1.3% |
| Q1 2016 | $1,705,000 | +33.5% | 41,494 | +24.0% | 0.08% | +34.5% |
| Q4 2015 | $1,277,000 | -99.8% | 33,475 | +34.5% | 0.06% | -17.1% |
| Q3 2015 | $817,670,000 | +38707.3% | 24,891 | -16.7% | 0.07% | -33.3% |
| Q2 2015 | $2,107,000 | +14.8% | 29,866 | +11.4% | 0.10% | +156.1% |
| Q1 2015 | $1,836,000 | -7.2% | 26,800 | -0.7% | 0.04% | -65.8% |
| Q4 2014 | $1,978,000 | -18.0% | 26,989 | -19.7% | 0.12% | -23.1% |
| Q3 2014 | $2,412,000 | +9.8% | 33,612 | +10.7% | 0.16% | +8.3% |
| Q2 2014 | $2,196,000 | +506.6% | 30,371 | +516.8% | 0.14% | +380.0% |
| Q1 2014 | $362,000 | – | 4,924 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |